CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NODSCID mouse

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2950-2960

  Sévère, Sabine ^a   Gauvrit, Anne ^a   Vu, Anh Tuan ^a   Bach, Jean Marie ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Antigens peptides epitopes; Autoimmunity; Cytotoxic T cell; Diabetes; Molecular biology

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; FEMALE; INSULITIS; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SCID MOUSE;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNIZATION; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 33947097878     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.008     Document Type: Article

References (42)

1. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., and Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406 (2000) 739-742
2. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23 (2005) 447-485
3. Bowie L., Tite J., and Cooke A. Generation and maintenance of autoantigen-specific CD8(+) T cell clones isolated from NOD mice. J. Immunol. Meth. 228 (1999) 87-95
4. Cetkovic-Cvrlje M., Gerling I.C., Muir A., Atkinson M.A., Elliot J.F., and Leiter E.H. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. Diabetes 46 (1997) 1975-1982
5. + clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. J. Immunol. 174 (2005) 2746-2755
6. Gagnerault M.C., Luan J.J., Lotton C., and Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196 (2002) 369-377
7. Gauvrit A., Debailleul M., Vu A.T., Sai P., and Bach J.M. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice. Clin. Exp. Immunol. 137 (2004) 253-262
8. Graser R.T., DiLorenzo T.P., Wang F., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., and Serreze D.V. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164 (2000) 3913-3918
9. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18 (2000) 927-974
10. Han B., Serra P., Amrani A., Yamanouchi J., Maree A.F., Edelstein-Keshet L., and Santamaria P. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11 (2005) 645-652
11. Jaeckel E., Klein L., Martin-Orozco N., and von Boehmer H. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J. Exp. Med. 197 (2003) 1635-1644
12. Jaeckel E., Lipes M.A., and von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5 (2004) 1028-1035
13. Katz J., Benoist C., and Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23 (1993) 3358-3360
14. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., and Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366 (1993) 69-72
15. Kim S.K., Tarbell K.V., Sanna M., Vadeboncoeur M., Warganich T., Lee M., Davis M., and McDevitt H.O. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14204-14209
16. Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Meth. 172 (1994) 227-239
17. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 8384-8388
18. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173 (2004) 6727-6734
19. Ma S.W., Zhao D.L., Yin Z.Q., Mukherjee R., Singh B., Qin H.Y., Stiller C.R., and Jevnikar A.M. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. 3 (1997) 793-796
20. Moriyama H., Abiru N., Paronen J., Sikora K., Liu E., Miao D., Devendra D., Beilke J., Gianani R., Gill R.G., and Eisenbarth G.S. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10376-10381
21. Nagata M., Yokono K., Hayakawa M., Kawase Y., Hatamori N., Ogawa W., Yonezawa K., Shii K., and Baba S. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 143 (1989) 1155-1162
22. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., and Eisenbarth G.S. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435 (2005) 220-223
23. Panina-Bordignon P., Lang R., van Endert P.M., Benazzi E., Felix A.M., Pastore R.M., Spinas G.A., and Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181 (1995) 1923-1927
24. Quinn A., McInerney M.F., and Sercarz E.E. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J. Immunol. 167 (2001) 1748-1757
25. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219. http://syfpeithi.bmi-heidelberg.com/scripts/MHCServer.dll/home.htm (access via http://syfpeithi.bmi-heidelberg.com/scripts/MHCServer.dll/home.htm)
26. Rammensee H.G., Friede T., and Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 41 (1995) 178-228
27. + T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. J. Immunol. 154 (1995) 2494-2503
28. Serreze D.V., Leiter E.H., Christianson G.J., Greiner D., and Roopenian D.C. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43 (1994) 505-509
29. Taki T., Nagata M., Ogawa W., Hatamori N., Hayakawa M., Hari J., Shii K., Baba S., and Yokono K. Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody. Diabetes 40 (1991) 1203-1209
30. Tarbell K.V., Lee M., Ranheim E., Chao C.C., Sanna M., Kim S.K., Dickie P., Teyton L., Davis M., and McDevitt H. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196 (2002) 481-492
31. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., and McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366 (1993) 72-75
32. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., Santamaria P., and Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111 (2003) 217-223
33. + cytotoxic T cell clone recognizes GAD65 and causes insulitis. J. Autoimmun. 20 (2003) 97-109
34. Vizler C., Bercovici N., Heurtier A., Pardigon N., Goude K., Bailly K., Combadiere C., and Liblau R.S. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J. Immunol. 165 (2000) 6314-6321
35. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., Podolin P.L., Zijlstra M., Jaenisch R., and Peterson L.B. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43 (1994) 500-504
36. Wilson S.S., White T.C., and DeLuca D. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo. J. Immunol. 167 (2001) 569-577
37. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., Shastri N., Pamer E.G., and Janeway Jr. C.A. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5 (1999) 1026-1031
38. Wong F.S., Visintin I., Wen L., Flavell R.A., and Janeway Jr. C.A. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183 (1996) 67-76
39. Yoon J.W., Yoon C.S., Lim H.W., Huang Q.Q., Kang Y., Pyun K.H., Hirasawa K., Sherwin R.S., and Jun H.S. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284 (1999) 1183-1187
40. Zechel M.A., Elliott J.F., Atkinson M.A., and Singh B. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11 (1998) 83-95
41. Zechel M.A., Krawetz M.D., and Singh B. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol. Rev. 164 (1998) 111-118
42. + Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101 (1998) 68-73